Lexicon Pharmaceuticals LXRX Operating Lease Liability Payments - 2026 (Lessee)
Operating Lease Liability Payments - 2026 (Lessee) at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's operating lease liability payments - 2026 (lessee).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's operating lease liability payments - 2026 (lessee)?
- Lexicon Pharmaceuticals (LXRX) reported operating lease liability payments - 2026 (lessee) of $1.72M in Q1 2026.
- How has Lexicon Pharmaceuticals's operating lease liability payments - 2026 (lessee) changed year-over-year?
- Lexicon Pharmaceuticals's operating lease liability payments - 2026 (lessee) increased by 95.0% year-over-year, from $881K to $1.72M.
- What does operating lease liability payments - 2026 (lessee) mean?
- This represents the specific cash outflow commitment for operating leases scheduled for the calendar year 2026. It allows investors to isolate the impact of real estate and equipment lease obligations on the company's cash flow in a specific future period.